Clinical Impacts of Histological Subtyping Primary Breast Cancer

被引:0
|
作者
Fritz, P. [1 ,6 ]
Klenk, S. [1 ]
Goletz, S. [1 ]
Gerteis, A. [3 ]
Simon, W. [3 ]
Brinkmann, F. [5 ]
Heidemann, E. [5 ]
Luetttgen, E. [2 ]
Ott, G. [2 ]
Alscher, M. D. [1 ]
Schwab, M. [6 ]
Dippon, J. [4 ]
机构
[1] Inst Digital Med, Stuttgart, Germany
[2] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany
[3] Robert Bosch Krankenhaus, Dept Gynecol, Stuttgart, Germany
[4] Univ Stuttgart, Fachbereich Math, Inst Stochast & Anwendung, Stuttgart, Germany
[5] Onkol Schwerpunkt Stuttgart, Stuttgart, Germany
[6] Klin Pharmakol Stuttgart, Margarethe Fischer Bosch Inst, Stuttgart, Germany
关键词
Breast cancer; histology; survival analysis; steroid receptors; INVASIVE LOBULAR CARCINOMA; SURVIVAL; TERM; CHEMOTHERAPY; THERAPY; STAGE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Treatment decisions in breast cancer depend on TNM classification and the assessment of additional variables with have an impact on survival. We examined whether histological subtyping breast cancer as either ductal or lobular is related to disease outcome. Patients and Methods: We examined a large data base of 14198 breast cancer patients. Results: Histological sub-classification of invasive breast cancer as either ductal or lobular is not correlated with disease outcome. However, the data further showed that invasive lobular carcinomas have a higher probability of being oestrogen receptor (ER)and progesterone receptor (PR)-positive and a lower probability of being c-erbB2-positive. They also showed a higher average age at the time of diagnosis in comparison with invasive ductal carcinoma. Local recurrence rates were lower in invasive lobular carcinoma in comparison with invasive ductal carcinoma (3.5% vs. 6.2%; p=0.031). The multivariable Cox regression analysis showed that ER, PR, nodal status, grade and tumour size predicted disease outcome with statistical significance, while the histological subtype (invasive ductal or lobular) was not a significant predictor of disease outcome. Conclusion: Histological sub-classification of invasive breast cancer as either ductal or lobular is not correlated with disease outcome. On the other hand our data gives some indication that lobular and ductal breast cancer appear to be different biological entities.
引用
收藏
页码:5137 / 5144
页数:8
相关论文
共 50 条
  • [1] Prognostic impact of histological subtyping in triple-negative breast cancer
    Grosse, Claudia
    Noack, Petar
    Grosse, Alexandra
    Preuss, Caroline Ines
    Schwarz, Heike Kathleen
    Gitter, Thomas
    Schrenk, Peter
    Frauchiger-Heuer, Heike
    Papassotiropoulos, Barbel
    Tausch, Christoph
    Maccio, Umberto
    Moch, Holger
    Langer, Rupert
    Varga, Zsuzsanna
    HUMAN PATHOLOGY, 2024, 152
  • [2] HISTOLOGICAL VARIANTS OF PRIMARY INVASION OF BREAST CANCER
    GORDELAD.AS
    VOPROSY ONKOLOGII, 1974, 20 (07) : 8 - 13
  • [3] Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
    E. H. Lips
    L. Mulder
    J. J. de Ronde
    I. A. M. Mandjes
    B. B. Koolen
    L. F. A. Wessels
    S. Rodenhuis
    J. Wesseling
    Breast Cancer Research and Treatment, 2013, 140 : 63 - 71
  • [4] Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
    Lips, E. H.
    Mulder, L.
    de Ronde, J. J.
    Mandjes, I. A. M.
    Koolen, B. B.
    Wessels, L. F. A.
    Rodenhuis, S.
    Wesseling, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (01) : 63 - 71
  • [5] Primary breast cancer in the elderly: a systematic literature review on histological type and clinical outcome
    Ogunbiyi, Samuel O.
    Lee, Sooyoung
    Mathew, John
    Cheung, Kwok Leung
    FUTURE ONCOLOGY, 2015, 11 (02) : 259 - 265
  • [6] Advances in Molecular and Clinical Subtyping of Breast Cancer and Their Implications for Therapy
    Cadoo, Karen A.
    Traina, Tiffany A.
    King, Tari A.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 22 (04) : 823 - +
  • [7] Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients
    Bichlien Nguyen
    Pino G. Cusumano
    Kenneth Deck
    Deborah Kerlin
    Agustin A. Garcia
    Julie L. Barone
    Edgardo Rivera
    Katharine Yao
    Femke A. de Snoo
    Jeroen van den Akker
    Lisette Stork-Sloots
    Daniele Generali
    Annals of Surgical Oncology, 2012, 19 : 3257 - 3263
  • [8] Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients
    Bichlien Nguyen
    Cusumano, Pino G.
    Deck, Kenneth
    Kerlin, Deborah
    Garcia, Agustin A.
    Barone, Julie L.
    Rivera, Edgardo
    Yao, Katharine
    de Snoo, Femke A.
    van den Akker, Jeroen
    Stork-Sloots, Lisette
    Generali, Daniele
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (10) : 3257 - 3263
  • [9] Male Breast Cancer: Histological and Clinical Features
    Balakrishnan, D.
    Tornos, C.
    Lu, J.
    Bien, H.
    O'Hea, B.
    Zee, S.
    Singh, M.
    Liu, J.
    MODERN PATHOLOGY, 2014, 27 : 37A - 37A
  • [10] Clinical and histological predictors of contralateral breast cancer
    Kollias, J
    Ellis, IO
    Elston, CW
    Blamey, RW
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (06): : 584 - 589